已收盘 08-21 16:00:00 美东时间
+0.240
+2.84%
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
XChange飙升348%,拟收购智能体公司加速AI保险转型;ARX劲升43%,获私募溢价近5成收购;奥麦罗制药升逾26%,Q2业绩强劲,EPS扭亏为盈大超预期>>
08-14 16:05
今日重点评级关注:古根海姆:维持Scynexis"买入"评级,目标价从24美元升至33美元;韦德布什:维持Kura Oncology"跑赢大市"评级,目标价从36美元升至38美元
08-14 11:51
LENSAR shares are trading higher after the company reported better-than-expected Q2 financial results.
08-14 02:30
BTIG analyst Ryan Zimmerman maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $7 to $9.
08-14 00:05
LENSAR (NASDAQ:LNSR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. Access...
08-13 21:22
LENSAR (NASDAQ:LNSR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.17) by 162.5 percent. This is a 166.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $16.495 million which ...
08-13 19:02
LENSAR ( ($LNSR) ) has provided an announcement. On August 4, 2026, LENSAR held...
08-11 06:18
LENSAR, Inc. announced that its second quarter 2026 financial results will be released before market open on Thursday, August 13, 2026. The company will host a conference call and webcast at 8:30 am ET on the same day to discuss the results, recent highlights, and strategic initiatives. Participants can register via the provided link, and the webcast will be available on the company’s Investor Relations website. LENSAR specializes in advanced rob...
08-06 12:00
Lensar Inc (($LNSR)) has held its Q1 earnings call. Read on for the main highli...
06-02 08:26